Dataset related to article: Unknown Immunoregulatory Effects of FcRn Inhibition by Efgartigimod in Myasthenia Gravis: A New Mechanism of Action Beyond IgG Reduction

Raw data derived by immunological and molecular analyses performed in myasthenia gravis (MG) patients treated with efgartigimod, an FcRn inhibitor drug, including: i) serum IgG and autoAb quantification by ELISA and RIA; ii) circulating T- and B-cell subpopulation analysis by flow cytometry; iii) gene expression analysis in peripheral blood mononuclear cells (PBMCs) by TaqMan qPCR; iv) FcRn staining in PBMCs by immunofluorescence.